期刊文献+

人端粒酶逆转录酶肿瘤相关反馈调节机制的研究进展 被引量:1

Research progress in the feedback regulation of telomerase reverse transcriptase related in cancer
下载PDF
导出
摘要 人端粒酶逆转录酶(human telomerase reverse transcriptase,h TERT)是端粒酶的催化亚单位,尤其是端粒酶活性的限速因子,大量转录因子参与h TERT的调节。h TERT在超过90%的肿瘤中表达,对肿瘤细胞的持续增殖发挥着重要作用。此外,h TERT能调节诸如细胞周期调控、细胞信号转导等不同细胞生物学过程中众多基因的表达。因此,h TERT在肿瘤中既是效应因子又是调节因子。然而,h TERT与其靶基因之间的相互作用机制还尚未完全明确。本综述重点关注不同的信号转导通路和基因参与h TERT的反馈调节及其机制,进一步认识端粒酶的非端粒延长功能,从而可能成为肿瘤治疗潜在的新靶点。 Telomerase reverse transcriptase ( TERT) is the catalytic component of telomerase, especially the rate limiting determinant of telomerase activity.A comprehensive network of transcription factors has been shown to be involved in the regulation of TERT.TERT has been reported to be over-expressed in more than 90%of cancers, thereby playing a criti-cal role in sustained proliferation and survival potentials of various cancer cells.Furthermore, accumulating evidence has suggested that TERT could modulate the expression of numerous genes involved in diverse group of cellular processes, in-cluding cell cycle regulation and cellular signaling.Therefore, it indicates that TERT is both an effector and a regulator in carcinoma.However, the mechanisms of the interaction between TERT and its target genes are still not fully understood.In this review, we focus on various signaling pathways and genes that participate in the feedback regulation of TERT and the underlying feedback regulation mechanism of TERT, to further provide new insights into non-telomeric functions of telom-erase and potentially novel therapeutic target for cancer.
出处 《大连医科大学学报》 CAS 2015年第6期605-609,共5页 Journal of Dalian Medical University
基金 国家自然科学基金项目(81173615)
关键词 人端粒酶逆转录酶(hTERT) 反馈调节 信号转导通路 肿瘤 telomerase reverse transcriptase (TERT) feedback regulation signal transdution pathway cancer
  • 相关文献

参考文献38

  • 1Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation[J]. Mol Biol Rep, 2011, 38(5): 3339-3349.
  • 2Shay JW, Bacchetti S. A survey of telomerase activity in human cancer[J]. Eur J Cancer, 1997, 33(5): 787-791.
  • 3Zvereva MI, Shcherbakova DM, Dontsova OA. Telomerase: structure, functions, and activity regulation[J]. Biochemistry(Mosc), 2010, 75(13): 1563-1583.
  • 4Perrault SD, Hornsby PJ, Betts DH. Global gene expression response to telomerase in bovine adrenocortical cells[J]. Biochem Biophys Res Commun, 2005, 335(3): 925-936.
  • 5Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter[J]. Hum Mol Genet, 1999, 8(1): 137-142.
  • 6Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit(hTERT)gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells[J]. Cancer Res, 1999, 59(3): 551-557.
  • 7Autexier C, Lue NF. The structure and function of telomerase reverse transcriptase[J]. Annu Rev Biochem, 2006, 75: 493-517.
  • 8Kirkpatrick KL, Newbold RF, Mokbel K. The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression[J]. J Carcinog, 2004, 3(1): 1.
  • 9Ghosh A, Saginc G, Leow SC, et al. Telomerase directly regulates NF-kappaB-dependent transcription[J]. Nat Cell Biol, 2012, 14(12): 1270-1281.
  • 10Xiang H, Wang J, Mao Y, et al. Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway[J]. Oncogene, 2002, 21(23): 3784-3791.

同被引文献13

  • 1蒋玉艳,何敏,杨莉,李开鹏.荧光定量PCR法检测肿瘤细胞端粒酶活性的变化[J].现代生物医学进展,2006,6(7):12-16. 被引量:1
  • 2鲁燕,陆轶群,程绪杰,薛枫,李红霞,陈弹,成兴波.1型糖尿病患者外周血白细胞端粒长度的变化及其意义[J].江苏医药,2007,33(2):127-128. 被引量:6
  • 3Zakian VA.Structure,function,and replication of Saccharomyces cerevisiae teleromes[J].Annu Rev Genet,1996,30(1):141-172.
  • 4Shay JW,Wright WE.Hallmarks of telomeres in ageing research[J].J Pathol,2007,211(2):114-123.
  • 5Fyhrquist F,Tiitu A,Saijonmaa O,et al.Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes[J].J Intern Med,2010,267(3):278-286.
  • 6Liu ZL,Zhang JH,Yan JT,et al.Leucocyte telomere shortening in relation to newly diagnosed type 2 diabetic patients with depression[J].Oxid Med Cell Longev,2014,2014:1-8.
  • 7程桦.糖尿病[M].7版.北京:人民卫生出版社,2009:365-371.
  • 8Wege H,Chui MS,Le HT,et al.SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity[J].Nucleic Acids Res,2003,31(2):E3.
  • 9Chen W,Chen SM,Yu Y,et al.Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells[J].J Laryngol Otol,2010,124(7):780-783.
  • 10Hiyama K,Hirai Y,Kyoizumi S,et al.Activation of telomerase in human lymphocytes and hematopoictic progenitor cells[J].J Immunol,1995,155(8):3711.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部